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Background: No resilience scale has been validated in Spanish patients with fibromyalgia. The aim of this study
was to evaluate the validity and reliability of the 10-item CD-RISC in a sample of Spanish patients with fibromyalgia.
Methods: Design: Observational prospective multicenter study. Sample: Patients with diagnoses of fibromyalgia
recruited from primary care settings (N = 208). Instruments: In addition to sociodemographic data, the following
questionnaires were administered: Pain Visual Analogue Scale (PVAS), the 10-item Connor-Davidson Resilience scale
(10-item CD-RISC), the Fibromyalgia Impact Questionnaire (FIQ), the Hospital Anxiety and Depression Scale (HADS),
the Pain Catastrophizing Scale (PCS), the Chronic Pain Acceptance Questionnaire (CPAQ), and the Mindful Attention
Awareness Scale (MAAS).
Results: Regarding construct validity, the factor solution in the Principal Component Analysis (PCA) was considered
adequate, so the KMO test had a value of 0.91, and the Barlett’s test of sphericity was significant (χ2 = 852.8; gl = 45;
p < 0.001). Only one factor showed an eigenvalue greater than 1, and it explained 50.4% of the variance. PCA and
Confirmatory Factor Analysis (CFA) results did not show significant differences between groups. The 10-item CD-RISC
scale demonstrated good internal consistency (Cronbach’s alpha = 0.88) and test-retest reliability (r = 0.89 for a six-week
interval). The 10-item CD-RISC score was significantly correlated with all of the other psychometric instruments in the
expected direction, except for the PVAS (−0.115; p = 0.113).
Conclusions: Our study confirms that the Spanish version of the 10-item CD-RISC shows, in patients with fibromyalgia,
acceptable psychometric properties, with a high level of reliability and validity.
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Fibromyalgia is a complex chronic disease, very often
difficult to diagnose and treat, and characterized by a set
of symptoms including chronic musculoskeletal pain,
allodynia, hyperalgesia, physical and psychological fa-
tigue, effort intolerance, sleep disturbance, and morning
stiffness [1,2]. Because of the associated high consump-
tion of health resources, high work absenteeism, and
high load of suffering for patients and their families,
fibromyalgia should be considered an important public
health issue [3-6].* Correspondence: blanca.notario@uclm.es
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distribution, and reproduction in any mediumEvidence suggests that among individuals with chronic
pain such as fibromyalgia, arthritis, or osteoarthritis,
psychological factors play a key role in the development
and maintenance of the disease [7]. Therefore, in recent
years, the number of resilience-related research projects
in patients with fibromyalgia has increased [8-10]. Resili-
ence, defined as the ability to recover from and adapt
positively to stress and adversity [11], is a multidimen-
sional construct determined by genetic, psychological,
social, biological, and environmental factors [11-15], and
its variability depends on context, time, age, and life cir-
cumstances [16]. Positive emotions have been described
as a key aspect of resilience, so that resilient individuals
use positive emotions to cope with stress and adverse
circumstances [17-20].d Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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such as depression or anxiety, are more prevalent in pa-
tients with fibromyalgia than in patients with rheumatic
diseases [10,21,22], and these patients may also suffer from
a relative absence of positive emotional resources [8,23,24].
Nevertheless, evidence suggests that resilient individuals
have higher levels of pain acceptance [25] and lower levels
of catastrophizing [26,27] and emotional distress [28].
Treatment strategies for fibromyalgia that combine
physical activity interventions with cognitive-behavioral
treatment in order to foster resilience-related factors
have been demonstrated to be equally as or more effect-
ive than either single treatment alone [29-34]. Therefore,
it is necessary to have valid and reliable instruments for
identifying those patients most vulnerable to adverse
events, so that they can benefit from these interventions
[14,35,36].
Different scales for assessing resilience have been vali-
dated in studies of chronic pain population. The Ego-
Resilience scale (ER-89) [37] was used to assess resilience
in a sample of patients suffering low back pain and osteo-
arthritis [26]. The Resilience Scale [38] has shown good
psychometrics properties in assessing resilience in patients
with both spinal chronic pain [39] and musculoskeletal
pain [40]. In another study [41], the CD-RISC scale [16]
has been used to assess the influence of resilience on de-
pressive symptoms in a sample of spinal cord injury pa-
tients, showing that resilience plays an important role in
the process of coping with a disability and seems to buffer
the occurrence of depressive symptoms.
As far as we know, no resilience scale has been vali-
dated in Spanish patients with fibromyalgia. The 10-item
CD-RISC [14] is a short version of the CD-RISC scale
that has proven good psychometric properties in Spanish
[42,43] and Chinese [44] populations. The aim of this
study was to evaluate the validity and reliability of the
10-item CD-RISC in a Spanish sample of patients with
fibromyalgia.
Methods
Study design and population
Our data come from the baseline measurements of an
observational prospective multicenter study including
patients with diagnoses of fibromyalgia, the methods of
which have been published elsewhere [45]. In brief, the
sample comprised consecutive patients (N = 208) with
fibromyalgia recruited from primary care settings by
their general practitioners at the city of Zaragoza, Spain,
from January to November, 2010. To be included in the
study, patients had to fulfill the American College of
Rheumatology criteria for primary fibromyalgia [46] ac-
cording to a diagnosis made by a Spanish National
Health Service rheumatologist and sign an informed
consent form. The exclusion criteria were medical orpsychiatric disorders that would impede the patient from
accurately answering the questionnaire, a diagnosis of a
concomitant chronic fatigue syndrome, to be involved in
any compensation claims, and poor knowledge of the
Spanish language. The overall prevalence of fibromyalgia
in adults in Spain is estimated at 2.4 and this syndrome
affects more women than men in a ratio of 21:1, increas-
ing with age [47]. This sex ratio is similar to the sample.
The study protocol was approved by the Clinical Research
Ethics Committee of Aragon (reference number CP08/07/
2009). All participants were asked to give their informed
consent orally and in writing, after a full explanation of
the research project. After consenting to the study,
sociodemographic data were collected, and a battery of
questionnaires was administered, which they completed
during the visit in which they were assessed at the hospital.
This battery included a Pain Visual Analogue Scale (PVAS)
for pain intensity and the validated Spanish versions of the
10-item Connor Davidson Resilience scale (10-item CD-
RISC), the Fibromyalgia Impact Questionnaire (FIQ), the
Hospital Anxiety and Depression Scale (HADS), the Pain
Catastrophizing Scale (PCS), the Chronic Pain Acceptance
Questionnaire (CPAQ), and the Mindful Attention Aware-
ness Scale (MAAS).
For the reliability analysis, both the 10-item CD-RISC




The 10-item CD-RISC [14] is a self-administered ques-
tionnaire including 10 items designed as a Likert-type
additive scale with five response options (0 = never; 4 =
almost always), which had a single dimension. The final
score on the questionnaire was the sum of the responses
obtained on each item (range 0–40), and the highest
scores indicated the highest level of resilience. The
Spanish validated version was used [42].
Fibromyalgia impact questionnaire (FIQ)
The FIQ [48] is a 10-item self-administered question-
naire developed to measure the health status in patients
with fibromyalgia. The first item focuses on the patient’s
ability to carry out muscular activities. In the next two
items, patients are asked to circle the number of days in
the past week they felt good and how often they missed
work. Finally, the last seven items are concerned with
job performance, pain, fatigue, morning tiredness, stiff-
ness, anxiety, and depression, and are measured by a
visual analogue scale (VAS). We used the Spanish ver-
sion, which psychometric characteristics have been dem-
onstrated (Cronbach α = 0.82; correlations coefficient
between differences in health status changes and FIQ
scores pre-post treatment = 0.72) [49].
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The PCS [50] is a 13-item self-administered question-
naire that comprises three dimensions: (a) rumination,
(b) magnification, and (c) helplessness. There is no es-
tablished “cut-off” point because pain catastrophizing is
considered a personality trait distributed in a continu-
ous way in the general population. The Spanish vali-
dated version was used; this version have demonstrated
good levels of internal consistency (Cronbach α = 0.79)
and test-retest reliability (intraclass correlation coeffi-
cient =0.84) [45].
Hospital anxiety and depression scale (HADS)
The HADS [35] is a 14-item, self-administered scale
with anxiety and depression being assessed by 7 items
each. Each item is scored from 0 to 3 with several an-
chors. Some items are assessed positively and others
negatively. A score between 0 and 21 points may be ob-
tained in each domain. The score in each domain may
be categorized into four severity groups: normal (0–7),
mild (8–10), moderate (15–21), and severe (15–21). The
Spanish version of HADS used in this study has evidenced
good levels of internal consistency (Cronbach’s α of 0.86
for anxiety and 0.86 for depression) [36]. HADS was se-
lected for use in the present study because it is considered
one of the best questionnaires for assessing depression
and anxiety in patients with pain disorders [36].
Pain visual analogue scale (PVAS)
The PVAS was designed to allow a subjective assessment
of pain. A VAS is usually a 10-cm horizontal line, with
perpendicular lines on the edges, defined as the extreme
limits of pain experience. Anchoring points at each
edges are characterized by verbal expressions such as
“No pain” (accompanied by the number “0”) at one end
and “maximum pain ever experienced” (accompanied by
the number “100”) at the other end. Previous studies
have demonstrated PVAS to have adequate psychometric
properties, including test-retest reliability (r = 0.78) and
convergent validity with other pain measures such as
McGill Pain Questionnaire (r = 0.49-0.65) [51].
The chronic pain acceptance questionnaire (CPAQ)
The CPAQ [52] is 20-item self-administered inventory
to asses pain acceptance. There are two principle factors
measured by this questionnaire: activities engagement
and pain willingness. All items are rated on a 0 (never
true) to 6 (always true) scale. The maximum possible
total score is 120, with a higher score indicating better
acceptance. We used the Spanish validated version that
shows adequate psychometric properties such as internal
consistency (Cronbach’s α: 0.83) and test-retest reliability
(intraclass correlation coefficient: 0.83) [53].The mindful attention awareness scale (MAAS)
The MAAS [54] is a 15-item self-administered question-
naire to assess mindfulness. Principal component analysis
(PCA) yielded a one-factor solution. The respondents
indicate how frequently they have the experience de-
scribed in each statement using a 6-point Likert scale from
1 (almost always) to 6 (almost never), where high scores
reflect more mindfulness. In an attempt to monitor for so-
cially desirable responses, respondents are asked to answer
according to what “really reflects” their experience rather
than what they think their experience should be. The
items are distributed across cognitive, emotional, physical,
interpersonal, and general domains. We used the Spanish
version that shows adequate psychometric properties in-
cluding internal consistency (Cronbach’s α = 0.89) [55].
Statistical analysis
Construct validity
PCA was used to examine the number of factors under-
lying the scale. Bartlett’s test of sphericity and the KMO
index were used to assess the suitability of the factor
solution. An eigenvalue of 1 was used as a criterion for
factor extraction. To determine the optimal number of
factors to retain in the PCA, the interpretability of the
factor loadings, Kaiser’s criterion (retention of factors
with eigenvalues greater than 1.0), and the scree test
were utilized. The scree test involves the examination of
a plot of the eigenvalues for breaks or discontinuities.
The logic behind the scree test is that the break point
divides the important factors from the minor factors.
The suitability of a single factor model underlying the
10-item CD-RISC was analyzed by confirmatory factor ana-
lysis (CFA) using IBM SPSS Amos 19 software. Although
sex differences in resilience have been described [56],
given that the male-to-female ratio is so unbalanced in
fibromyalgia, analyses by sex were not considered feas-
ible. The goodness of fit of the hypothetical model to
the sample data was assessed according to the Hu and
Bentler criteria [57]. To test the factor structure of the
10-item CD-RISC, we randomly split the sample into
two subsamples and conducted PCA and CFA in these
two sub-samples, respectively.
Convergent validity
Partial correlation coefficients were used to examine the
relationship between the total 10-item CD-RISC score
and other theoretically related constructs used as criter-
ion variables, including chronic pain acceptance, cata-
strophizing, fibromyalgia, mindfulness, and pain.
Reliability
The reliability of 10-item CD-RISC was examined in
terms of internal consistency and test-retest reliability.
Internal consistency was evaluated by Cronbach’s alpha
Table 1 Sociodemographic characteristics of the study
sample (n = 208)















No schooling 6 (2.9%)
Primary level 93 (44.7%)
Secondary level 80 (38.5%)





Sick leave 30 (14.4%)
Retired 28 (13.5%)
Disable 44 (21.2%)
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items. Test-retest reliability was evaluated in the 191 pa-
tients in whom the 10-item CD-RISC was administered
twice: at baseline and six weeks later. Both the Spearman
correlation coefficient and the intra-class correlation co-
efficient (ICC) between the scores at baseline and six
weeks later were used to estimate its reproducibility.
The hypothesis that the standard psychometric recom-
mendations for Cronbach’s alpha and ICC were greater
than or equal to 0.7 was taken as a starting point for
both internal consistency and test-retest reliability [58].
Responsiveness
As in other studies [59-62], we used responsiveness as
the ability of an instrument to detect differences be-
tween two points in time (change over time) within
groups. Since resilience is a construct highly influenced
by stressful life events, and that for people with fibro-
myalgia probably the most stressful event on a day-to-
day basis is the evolution of their disease, we have tested
whether changes in the evolution of fibromyalgia were
associated to changes in 10-item CD-RISC as an indirect
measure of sensitivity to changes in the 10-item CD-
RISC. Therefore, responsiveness was evaluated measur-
ing the test-retest mean differences, effect sizes, and
standardized response means (SRM) of the scores on the
10-item CD-RISC scale by categories of change (tertile)
on the FIQ scores. We calculated the effect size as fol-
lows: ES = (M1 −M0)/SDbas. M0 denotes the mean
score of the baseline assessment, M1 the mean score of
the follow-up assessment at time 1, and SDbas is the
standard deviation of the baseline assessment. SRM was
defined as: SRM = (M1 −M0)/SDMxMo, where the nu-
merator is the same as in case of the ES, and the denom-
inator is the standard deviation of the difference in score
at baseline and after time 1. Scores of effect size ≥ |0.8|
were considered as large effect, scores from ≥ |0.5| to < |
0.8| as medium, scores from ≥ |0.2| to < |0.5| as small
and scores ≥ |0.1| to |0.2| as trivial [63]. The same cut-
off levels were considered for evaluating the SMR, but
after transformation in an equivalent of Cohen’s d as fol-
lows [63]: d = d’/(√1 − r).
Except for CFA, analyses were performed with IBM
SPSS Statistics 19 software.
Results
Sample characteristics are described in Table 1. The final
study included 208 patients, 199 women (95.7%), and 9
men (4.3%), aged 31–66 (mean 52.37, SD: 8.35 years).
Each of the subjects described themselves as being of
European ethnic origin. The ratio of men to women in
the sample was approximately 1:20, similar to the preva-
lence of FM syndrome sex ratio in population samples.
On average, the patients who participated in the studyhad suffered from FM for 17.58 years (range 1–45; SD:
10.08 years). There were no significant differences in
10-item CD-RISC scores by sex. None of the partici-
pants scored 0 on the scale (floor effect), and 1.93% of
subjects obtained the maximum score (ceiling effect).Construct validity
The factor solution in the PCA was considered adequate,
so that the KMO test showed a value of 0.91, and the
Barlett’s test of sphericity was significant (χ2 = 852.8;
gl = 45; p < 0.001). Only one factor showed an eigen-
value greater than 1. This factor explained 50.4% of the
variance. The saturation of each item in the PCA ranged
from 0.87 to 0.89 across the 10 resilience items. The scree
plot showed a single suitable factor solution (Figure 1).Confirmatory factor analysis
The single factor model proposed for the CFA of the 10-








Figure 1 Sedimentation graph of factor components of 10-item CD-RISC.
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0.96, and SRMR= 0.041).
When we randomly split the sample into two groups,
the PCA and CFA results did not show significant differ-
ences between groups.
Convergent validity
Partial correlation coefficients were used to assess the rela-
tionship between the 10-item CD-RISC and other theoret-
ically related instruments (Table 2). The 10-item CD-RISC
score was significantly correlated (negative associationFigure 2 Factor loading and goodness-of-fit indexes of one-factor
model for the 10-items CD-RISC factor structure. Total sample:
n = 208; χ2 = 68.215; df = 35; p = 0.001; CFI = 0.96; and SRMR = 0.041.with FIQ, PCS, and HADS and positive association with
CPAQ and MAS) with all of the other psychometric in-
struments, except for the VAS (−0.115; p = 0.113).Reliability
The estimates of Cronbach’s α for the items included in
the 10-item CD-RISC was 0.88 and did not increase
after eliminating any of the items. Item-total correlation
coefficients ranged from 0.25 to 0.63 (median = 0.44).
The ICC between scores of the 10-item CD-RISC ques-
tionnaire administered at baseline and six weeks later
was 0.87 (95% CI = 0.83–0.90), the Spearman correlation
coefficient was 0.89 (p < 0.001). The paired Student’s
t-test did not find significant differences (p = 0.546)Table 2 Partial correlations among scores of 10-item
CD-RISC and measures fibromyalgia impact, pain
catastrophizing, anxiety, depression, pain, pain acceptance,
and mindfulness (n = 208)
Variables Correlation P
FIQ −0.32 <0.001






Abbreviations: PVAS Pain Visual Analogue Scale, 10-item CD-RISC 10-item Connor
Davidson Resilience scale, FIQ Fibromyalgia Impact Questionnaire, HADS Hospital
Anxiety and Depression Scale, PCS Pain Catastrophizing Scale, CPAQ Chronic Pain
Acceptance Questionnaire, MAAS Mindful Attention Awareness Scale.
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and after six-week follow-up.
Responsiveness
The test-retest mean differences, effect sizes, and stan-
dardized response means (SRM) by categories of change
(tertile) on the FIQ scores, are shown in Table 3. The
effect size of changes in 10-item CD-RISC in patients
whose scores in FIQ had improved or worsened ranged
from 0.2 to 0.45 and was negligible in those patients
whose FIQ score was similar at baseline and at the end
of the follow-up. The test-retest mean differences in the
10-item CD-RISC scores by category of change in FIQ
score were statistically significant.
Discussion
Our study confirms that the Spanish version of the 10-item
CD-RISC shows, in patients with fibromyalgia, acceptable
psychometric properties, with a high level of reliability and
validity. The characteristic of our study sample represents
the general characteristics of patients with fibromyalgia:
middle-aged women with several years of duration of the
disorder and on invalidity pensions [64].
The 10-item CD-RISC total score in our sample of pa-
tients with FM is lower compared with the young
adults’ sample studied in the original validation study [42].
These data are consistent with other studies, which
indicate that patients with FM show higher levels of
psychological distress and lower levels of resilience than
the general population and patients with other rheum-
atic disease [9,65]. A deficit in the functioning of the
hypothalamic-pituitary-adrenal axis in patients with FM
might be responsible for the lower levels of the resili-
ence in those patients; additionally, this deficit may
exacerbate the symptoms as a consequence of the mal-
adaptive response to stress that many of these patients
exhibit [66].
Construct validity and reliability
All of the statistical (PCA and CFA) and graphical ana-
lyses (scree plot) confirm that a single factor underliesTable 3 Mean change differences in 10-item CD-RISC scores a
(tertiles) on the FIQ scores during this follow up
10-item CD-RISC score
Worse (n = 61)
Baseline mean (SD) 19.89 (9.33)
Follow-up mean (SD) 17.59 (11.65)
Mean difference (SD) 2.29 (5.14)
Effect size 0.25
Standardized response mean 0.45
Cohen’s d 0.20
*p < 0.001.the resilience construct measured by the 10-item CD-
RISC in patients with FM, which is consistent with other
studies [43,44], and with the original Spanish validation
study of the 10-item CD-RISC [42]. Additionally, the scale
demonstrated good internal consistency (Cronbach’s alpha =
0.88) and test-retest reliability (r = 0.89 for a six-week inter-
val), supporting the stability of the scale. The reliability of
the scale was similar to that of the 10-item CD-RISC
original Spanish version (Cronbach’s α of the original
Spanish version = 0.85 and of the scale in FM patients =
0.88), and the weights in factor analysis were within the
range of 0.25–0.63 in our study and within the range of
0.48–0.76 in the original.
Convergent validity
Our data show a negative association between resilience
and mood disorder and, conversely, a positive association
between resilience and sense of purpose in life, findings in
line with Ruiz-Párraga et al. [40] and Catalano et al. [41]
that suggest that resilience may buffer against depressive
and anxiety symptoms and have a protective effect on
physical and psychological wellbeing.
On the other hand, it has been described that catastro-
phization increases pain severity, disability and emo-
tional distress [67] and plays a more important role in
the pain and depression of women with FMS than in
women with other chronic pain conditions [68]. More-
over, previous studies have found that resilient individ-
uals with severe chronic pain tend to report better
acceptance of pain than non-resilient individuals with
equal levels of pain intensity [27,40]. The lack of associ-
ation between resilience and VAS could be explained be-
cause resilience is more associated with the acceptance
and modulation of pain than with the severity of pain as
such. However, this hypothesis should be confirmed with
specifically designed studies.
Responsiveness
As mentioned above, to examine the responsiveness of
measures of a generic construct such as resilience, which
is highly influenced by stressful events that an individualt baseline and after six weeks by categories of change
FIQ scores
Similar (n = 67) Better (n = 63)
26.06 (6.81) 28.27 (8.08)*
26.04 (6.95) 31.21 (11.02)*
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pecially when changes in the construct are to be pro-
duced in only six weeks. The rationale of resiliency
model proposed by Richardson GE [69] suggest that the
key to protection from biopsychospiritual homeostasis
disruption is how the individual negotiates with life
events or stressors. In this model, the individual will ad-
just the level of homeostasis in four ways: resilient re-
integration, that reflects the optimal level of adaptation;
homeostatic reintegration, the individual returns to the
same level of functioning prior to the life event; mal-
adaptive reintegration, the individual moves to a lower
level of homeostasis after the life event; and dysfunc-
tional reintegration, the individual respond reflects dys-
functional behaviors and needs psychotherapy. Since
there is not a gold standard to evaluate resilience, and
following the Resiliency Model, we hypothesize that the
resilience construct should be correlated with fibromyal-
gia severity levels, and therefore individuals with lower
mean scores in 10-item CD-RISC at baseline (close to
first quartile) will decrease their resilience levels if the
severity of the disease increases.
For this reason, we have linked the measurement of
changes in resilience to changes in the development of
fibromyalgia measured by the FIQ. Our data confirm the
negative association between the changes in the levels
of resilience with the course of fibromyalgia syndrome
measured by FIQ scores and constitute indirect evidence
of responsiveness of 10-item CD-RISC.
Nonetheless, these results should be interpreted with
caution given the limitations of this study. First, as in any
study using self-report measures, the results may have
been influenced by participants’ acquiescence and need for
social desirability. Second, we did not asses this tool in
populations of patients with other types of chronic pain;
thus we did not confirm whether the factor structure is or
is not specific to fibromyalgia. Third, the overwhelming
proportion of women limits the generalizability of the
findings to men though some characteristic of the study
sample support that represents fairly well the population
of patients with fibromyalgia (i.e. the overall prevalence of
fibromyalgia in adults in Spain is 2.4%, and the women/
men ratio 21:1, figures similar to those our study) [47].
Conclusions
Considering that treatments that include interventions
for promoting resilience might be effective in patients
with FM, our study may have importance from the clin-
ical and research point of view, so that it provides a
short and clinically practical tool to assess resilience in
Spanish patients suffering from fibromyalgia. Our results
confirm the adequate psychometric properties of the 10-
item CD-RISC and the factor structure stability across
different cultures and populations.Competing interests
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